dalteparin has been researched along with Vasculitis, Retinal in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turaka, K | 1 |
| Bryan, JS | 1 |
| Kwong, HM | 1 |
| Ziemianski, MC | 1 |
1 other study available for dalteparin and Vasculitis, Retinal
| Article | Year |
|---|---|
Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiphospholipid Syndrom | 2012 |